Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | CNR2 | P34972 | 11/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | CNR1 | P21554 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25446809 | 1.00 | ALDH1A1 (0.51) | ALDH1A1SMN1; SMN2CNR2KDM4ETDP1 | |
| SCHEMBL24003154 | 0.92 | CNR2 (0.53) | ALDH1A1SMN1; SMN2CNR2KDM4ELMNA | |
| SCHEMBL30187103 | 0.92 | CNR2 (0.53) | ALDH1A1SMN1; SMN2CNR2KDM4ELMNA | |
| SCHEMBL30187154 | 0.91 | CNR2 (0.61) | ALDH1A1SMN1; SMN2CNR2CNR1 | |
| SCHEMBL24003102 | 0.91 | CNR2 (0.61) | ALDH1A1SMN1; SMN2CNR2CNR1 | |
| SCHEMBL24002697 | 0.91 | CNR2 (0.49) | ALDH1A1SMN1; SMN2CNR2KDM4ELMNA | |
| SCHEMBL30187163 | 0.90 | CNR2 (0.53) | ALDH1A1SMN1; SMN2CNR2CNR1 | |
| SCHEMBL24003080 | 0.90 | CNR2 (0.53) | ALDH1A1SMN1; SMN2CNR2CNR1 | |
| SCHEMBL24003104 | 0.85 | ALDH1A1 (0.56) | ALDH1A1SMN1; SMN2CNR2KDM4ELMNA | |
| SCHEMBL24937592 | 0.84 | CNR2 (0.68) | CNR2CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115835909-B | Cannabinoid receptor type 2 (CB 2) modulators and uses thereof | 泰昂治疗公司 | 2026-05-15 | — | — | CN | disclosed |
| CN-115835909-A | Cannabinoid receptor type 2 (CB 2) modulators and uses thereof | 泰昂治疗公司 | 2023-03-21 | — | — | CN | disclosed |
| EP-4146345-A2 | CANNABINOID RECEPTOR TYPE 2 (CB2) MODULATORS AND USES THEREOF | Teon Therapeutics, Inc. (US) | 2023-03-15 | — | — | EP | disclosed |